Skip to main content

Residential Fine Particulate Matter Tied to Higher Dementia Risk

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

THURSDAY, Aug. 17, 2023 -- Higher residential levels of fine particulate matter (PM2.5) are associated with higher rates of incident dementia, according to a study published online Aug. 14 in JAMA Internal Medicine.

Boya Zhang, Ph.D., from the University of Michigan School of Public Health in Ann Arbor, and colleagues examined associations of long-term exposure of total and source-specific PM2.5 with incident dementia in older adults. The analysis included 27,857 participants in the Environmental Predictors of Cognitive Health and Aging study (1998 through 2016).

The researchers found that higher concentrations of total PM2.5 were associated with greater rates of incident dementia (hazard ratio, 1.08 per interquartile range). PM2.5 from all sources, except dust, was associated with increased rates of dementia in single pollutant models, with the strongest associations for agriculture, traffic, coal combustion, and wildfires. When adjusting for PM2.5 from all other sources and copollutants, only PM2.5 from agriculture (hazard ratio, 1.13) and wildfires (hazard ratio, 1.05) was robustly associated with greater rates of dementia.

These findings, the authors write, provide "further evidence supporting PM2.5 reduction as a population-based approach to promote healthy cognitive aging."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted August 2023

Read this next

Self-Administered Gerocognitive Exam Improves Detection of Cognitive Issues in Primary Care

TUESDAY, July 2, 2024 -- A self-administered gerocognitive examination (SAGE) is easily incorporated into primary care provider (PCP) visits, and its use significantly increases...

Emergence of Psychosis in Alzheimer Disease Linked to Elevations in p-tau181

MONDAY, July 1, 2024 -- For individuals with Alzheimer disease (AD), the emergence of psychosis is associated with elevations in levels of plasma tau phosphorylated at threonine...

Cognitive Impairment Delayed With Genetic Variant

THURSDAY, June 20, 2024 -- Cognitive impairment is delayed among persons who are heterozygous for the apolipoprotein E3 Christchurch variant (APOE3Ch), according to a study...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.